Literature DB >> 9525952

Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C.

A Ristimäki1, K Narko, B Enholm, V Joukov, K Alitalo.   

Abstract

Vascular endothelial growth factor (VEGF) is a prime regulator of normal and pathological angiogenesis. Three related endothelial cell growth factors, VEGF-B, VEGF-C, and VEGF-D were recently cloned. We have here studied the regulation of VEGF-C, a lymphatic endothelial growth factor, by angiogenic proinflammatory cytokines. Interleukin (IL)-1beta induced a concentration- and a time-dependent increase in VEGF-C, but not in VEGF-B, mRNA steady-state levels in human lung fibroblasts. The increase in VEGF-C mRNA levels was mainly due to increased transcription rather than elevated mRNA stability as detected by the nuclear run-on method and by following mRNA decay in the presence of an inhibitor of transcription, respectively. In contrast, angiopoietin-1 mRNA, encoding the ligand for the endothelial-specific Tek/Tie-2 receptor, was down-regulated by IL-1beta. Tumor necrosis factor-alpha and IL-1alpha also elevated VEGF-C mRNA steady-state levels, whereas the IL-1 receptor antagonist and dexamethasone inhibited the effect of IL-1beta. Experiments with cycloheximide indicated that the effect of IL-1beta was independent of protein synthesis. Hypoxia, which is an important inducer of VEGF expression, had no effect on VEGF-B or VEGF-C mRNA levels. IL-1beta and tumor necrosis factor-alpha also stimulated the production of VEGF-C protein by the fibroblasts. Cytokines and growth factors have previously been shown to down-regulate VEGF receptors in vascular endothelial cells. We found that the mRNA for the VEGF- and VEGF-C-binding VEGFR-2 (KDR/Flk-1) was stimulated by IL-1beta in human umbilical vein endothelial cells, whereas the mRNA levels of VEGFR-1 (Flt-1) and VEGFR-3 (Flt-4) were not altered. Our data suggest that in addition to VEGF, VEGF-C may also serve as an endothelial stimulus at sites of cytokine activation. In particular, these results raise the possibility that certain proinflammatory cytokines regulate the lymphatic vessels indirectly via VEGF-C.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525952     DOI: 10.1074/jbc.273.14.8413

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  114 in total

Review 1.  Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.

Authors:  K Narko; B Enholm; T Mäkinen; A Ristimäki
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

2.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.

Authors:  Elena Gallego; Luis Vicioso; Martina Alvarez; Isabel Hierro; Lidia Pérez-Villa; Alfredo Blanes; Alfredo Matilla
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

Review 4.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

Review 5.  Myeloid cells and lymphangiogenesis.

Authors:  Adrian Zumsteg; Gerhard Christofori
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 6.  Preclinical lymphatic imaging.

Authors:  Fan Zhang; Gang Niu; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

Review 7.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

8.  TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.

Authors:  Hiroshi Kinashi; Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Takeshi Terabayashi; Fumiko Nagura; Ryohei Hattori; Yoshihisa Matsukawa; Tomohiro Mizuno; Yukihiro Noda; Hayato Nishimura; Ryosuke Nishio; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Yoshifumi Takei
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

9.  Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.

Authors:  Souheil El-Chemaly; Daniela Malide; Enrique Zudaire; Yoshihiko Ikeda; Benjamin A Weinberg; Gustavo Pacheco-Rodriguez; Ivan O Rosas; Marta Aparicio; Ping Ren; Sandra D MacDonald; Hai-Ping Wu; Steven D Nathan; Frank Cuttitta; J Philip McCoy; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

10.  Angiopoietin-2 in experimental colitis.

Authors:  Vijay C Ganta; Walter Cromer; Ginny L Mills; James Traylor; Merilyn Jennings; Sarah Daley; Benjamin Clark; J Michael Mathis; Michael Bernas; Moheb Boktor; Paul Jordan; Marlys Witte; J Steven Alexander
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.